Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Roth Capital biotech analyst to hold an analyst/industry conference call » 13:25
04/09/20
04/09
13:25
04/09/20
13:25
AMRN

Amarin

$6.14 /

+0.33 (+5.68%)

, MTNB

Matinas BioPharma

$0.55 /

+0.0134 (+2.50%)

Biotechnology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Fly Intel: Wall Street's top stories at midday » 13:08
04/09/20
04/09
13:08
04/09/20
13:08
DIS

Disney

$106.00 /

+5.02 (+4.97%)

, GE

General Electric

$7.33 /

+0.025 (+0.34%)

, SBUX

Starbucks

$73.23 /

+1.74 (+2.43%)

, BIG

Big Lots

$19.37 /

+3.61 (+22.91%)

, NLS

Nautilus

$3.60 /

+1.195 (+49.79%)

, VRAY

ViewRay

$2.65 /

-0.07 (-2.57%)

, EXTR

Extreme Networks

$2.93 /

-0.195 (-6.24%)

Stocks are extending…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Nevro says court upholds patent claims validity in Boston Scientific case » 12:45
04/09/20
04/09
12:45
04/09/20
12:45
NVRO

Nevro

$108.49 /

+0.2 (+0.18%)

, BSX

Boston Scientific

$36.27 /

+1.16 (+3.30%)

Nevro (NVRO) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Iovance 'could be name to keep eye on' if Gilead seeks M&A, Dealreporter says » 09:47
04/09/20
04/09
09:47
04/09/20
09:47
IOVA

Iovance Biotherapeutics

$31.24 /

+0.34 (+1.10%)

, GILD

Gilead

$74.03 /

-0.95 (-1.27%)

After Gilead (GILD) gave…

After Gilead (GILD) gave soft guidance for this year, Dealreporter told its readers that if the pharma giant "were to go back to the well in oncology, Iovance Biotherapeutics (IOVA) could be a name to keep an eye on," sources tell The Fly. The biotech company reportedly saw some interest in February and such a hypothetical deal would give Gilead "another shot on goal in cell therapy" to build on its prior acquisition of Kite Pharma, the report added, according to contacts.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Disney+ could reach almost 70M subscribers by end of June, says Rosenblatt » 09:11
04/09/20
04/09
09:11
04/09/20
09:11
DIS

Disney

$100.98 /

-0.12 (-0.12%)

After Disney announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Disney remains top idea at JPMorgan after 'surprise' announcement » 09:07
04/09/20
04/09
09:07
04/09/20
09:07
DIS

Disney

$100.98 /

-0.12 (-0.12%)

JPMorgan analyst Alexia…

JPMorgan analyst Alexia Quadrani says Disney remains a top idea after the company announced that Disney+ has reached over 50M paid subscribers just under five months following its launch on November 12, 2019. The "surprise" announcement was provided amid the downward estimate revisions across other areas of the business, Quadrani tells investors in a research note. The analyst views Disney+ as a core driver to Disney's "extensive ecosystem of consumer touchpoints." She keeps an Overweight rating on the shares with a $140 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Largest borrow rate increases among liquid names » 08:45
04/09/20
04/09
08:45
04/09/20
08:45
SPCE

Virgin Galactic

$15.39 /

+1.36 (+9.69%)

, CRC

California Resources

$1.43 /

+0.19 (+15.32%)

, TLRY

Tilray

$6.98 /

+0.61 (+9.58%)

, WTRH

Waitr Holdings

$0.99 /

-0.0401 (-3.89%)

, JCP

J.C. Penney

$0.32 /

-0.008 (-2.43%)

, JNK

SPDR Barclays High Yield Bond

$95.26 /

+2.17 (+2.33%)

, FSLY

Fastly

$20.88 /

+1.04 (+5.24%)

, FXE

Euro Currency Trust

$102.63 /

-0.49 (-0.48%)

, MLCO

Melco Resorts & Entertainment

$12.80 /

+0.47 (+3.81%)

, MTCH

Match Group

$68.99 /

-1.22 (-1.74%)

Latest data shows the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Wells Fargo to hold a virtual conference » 08:27
04/09/20
04/09
08:27
04/09/20
08:27
ADVM

Adverum Biotechnologies

$10.76 /

+0.92 (+9.35%)

, ALLK

Allakos

$54.51 /

+4.58 (+9.17%)

, AGTC

Applied Genetic

$3.35 /

+0.17 (+5.35%)

, ARNA

Arena Pharmaceuticals

$48.05 /

+1.36 (+2.91%)

, ARWR

Arrowhead

$31.54 /

+2.2 (+7.50%)

, AUTL

Autolus Therapeutics

$7.05 /

+0.52 (+7.96%)

, AVRO

Avrobio

$13.75 /

+0.36 (+2.69%)

, BLCM

Bellicum Pharmaceuticals

$4.80 /

-0.05 (-1.03%)

, BMRN

BioMarin

$79.42 /

-0.41 (-0.51%)

, FATE

Fate Therapeutics

$25.64 /

+1.57 (+6.52%)

, FPRX

Five Prime

$2.44 /

+0.04 (+1.67%)

, GBT

Global Blood Therapeutics

$62.25 /

+3.7 (+6.32%)

, IONS

Ionis Pharmaceuticals

$52.53 /

+2.54 (+5.08%)

, IOVA

Iovance Biotherapeutics

$30.90 /

+1.19 (+4.01%)

, KZR

Kezar Life Sciences

$3.80 /

+0.04 (+1.06%)

, MEIP

MEI Pharma

$1.54 /

+0.03 (+1.99%)

2020 Virtual San…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Disney+ 50M paid subscribers a clear positive for streaming, says Credit Suisse » 08:14
04/09/20
04/09
08:14
04/09/20
08:14
DIS

Disney

/

+

Credit Suisse analyst…

Credit Suisse analyst Douglas Mitchelson notes that Disney (DIS) announced it hit 50M paid subscribers, with about 42M of those from North America/Western Europe markets and about 8M from India. Thus, Disney+ has added 14M developed market subscribers from the last reported February 4th 28M subscriber count through April 7th, reaching a level he did not expect until the end of the June quarter. This is a clear positive for the value Disney is creating in streaming as it suggests churn off its record Q4 launch has been at least manageable, if not low; the launches in 8 Western European markets likely have gone quite well; and Disney is clearly tracking way ahead of its guidance, having already achieved 70% of the low end of its 5-year 60M-90M guidance range ex-India in only 5 months. Overall, Disney is proving to be a fast follower in streaming, but Mitchelson would point out Disney+ outperformance only increases his confidence that Netflix (NFLX) is also seeing stay-at-home strength in March/April. He has an Outperform rating and $140 price target on Disney's stock.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Unusual call flow in option market yesterday » 07:35
04/09/20
04/09
07:35
04/09/20
07:35
AMRN

Amarin

$5.81 /

+0.78 (+15.51%)

, MRVL

Marvell

$24.74 /

+0.88 (+3.69%)

, I

Intelsat

$1.65 /

+0.575 (+53.74%)

, COOP

Mr. Cooper

$7.16 /

+1.2 (+20.13%)

, DVA

DaVita

$76.85 /

+4.71 (+6.53%)

Notable call activity was…

Notable call activity was cited Wednesday in Amarin (AMRN), Marvell (MRVL), Intelsat (I), Mr Cooper Group (COOP), and DaVita (DVA).

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.